Dr. Harry P. Erba
Overview
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians.
Dr. Erba is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 134 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Erba has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
Duke Hematologic Malignancies Clinic
I have over twenty years of experience as a hematologist-oncologist focusing in hematologic malignancies, leukemias, lymphomas, myeloma, and myelodysplastic and myeloproliferative syndromes. My patient care philosophy stresses interactive discussions with patients and their families on what to expect from the illness and treatment options, making sure that all their concerns and questions are addressed. Caring for patients with cancer is complex and my care team is dedicated to helping patients with the family, social, emotional, and financial issues, in addition to compassionate medical care. Dr. Kirby is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, and Bone Marrow Aspiration.
Duke Blood Cancer Center
I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
Duke Health Integrated Practice Inc
Danielle Brander is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Brander is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Leukemia, and Bone Marrow Aspiration. Dr. Brander is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- LeukemiaDr. Erba isElite. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Erba isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myelomonocytic LeukemiaDr. Erba isDistinguished. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Erba isDistinguished. Learn about Acute Promyelocytic Leukemia.
- Childhood Acute Myeloid LeukemiaDr. Erba isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Advanced
- Aplastic AnemiaDr. Erba isAdvanced. Learn about Aplastic Anemia.
- Ataxia-Pancytopenia SyndromeDr. Erba isAdvanced. Learn about Ataxia-Pancytopenia Syndrome.
- Bone Marrow AspirationDr. Erba isAdvanced. Learn about Bone Marrow Aspiration.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelomonocytic Leukemia (CMML)
- Experienced
- Acute Erythroid Leukemia (AEL)Dr. Erba isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Monoblastic Leukemia (AmoL)Dr. Erba isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- AgranulocytosisDr. Erba isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Erba isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- AnemiaDr. Erba isExperienced. Learn about Anemia.
- B-Cell LymphomaDr. Erba isExperienced. Learn about B-Cell Lymphoma.